Drug Profile
Estradiol transdermal - Bayer HealthCare Pharmaceuticals
Alternative Names: Climara; Estradiol transdermal - Berlex/3M; Femtran; Progynova TS 100; Progynova TS 50; Progynova TS ForteLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator 3M Pharmaceuticals; Bayer HealthCare Pharmaceuticals
- Developer 3M Pharmaceuticals; AbbVie; Bayer HealthCare Pharmaceuticals Inc.
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
- 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)